1Okemoto K,Kawasaki K,Hanada K,et al.Apotent Adjuvant Monophosphoryl Lipid A Triggers Various Immune Responses,but not Secretion of IL-1beta or Activation of Caspase-1[J].J Immunol,2006,176(2):1203-1208.
2Mata-Haro V,Cekic C,Martin M,et al.The Vaccine Adjuvant Monophosphoryl Lipid A as a TRIF-biased Agonist of TLR4[J].Science,2007,316(5831):1628-1632.
3Martin M,Michalek S M,Katz J.Role of Innate Immune Factors in the Adjuvant Activity of Monophosphoryl Lipid A[J].Infect Immun,2003,71(5):2498-2507.
4Boukhvalova M S,Prince G A,Soroush L,et al.The TLR4 Agonist,Monophosphoryl Lipid A,Attenuates the Cytokine Storm Associated with Respiratory Syncytial Virus Vaccine-enhanced Disease[J].Vaccine,2006,24(23):5027-5035.
5Garcon N,Chomez P,Van M M.GlaxoSmithK Line Adjuvant Systems in Vaccines:Concepts,Achievements and Perspectives[J].Expert Rev Vaccines,2007,6(5):723-739.
6Casella C R,Mitchella T C.Putting Endotoxin to Work for Us:Monophosphoryl Lipid A as a Safe and Effective Vaccine Adjuvant[J].Cellular and Molecular Life Sciences,2008,65(20):3231-3240.
7Harandi A M,Medaglini D,Shattock R J.Vaccine Adjuvants:A Priority for Vaccine Research[J].Vaccine,2010,28(12):2363-2366.
8Laddy D J,Weiner D B.From Plasmids to Protection:a Review of DNA Vaccines against Infectious Diseases[J].Int Rev Immunol,2006,25(3/4):99-123.
9Cox J C,Coulter A R.Adjuvants a Classification and Review of Their Modes of Action[J].Vaccine,1997,15(3):248-256.
10Rakhmilevich A L,Janssen K,Turner J,et al.Cytokine Gene Gun Therapy of Cancer Using Gene Gun Technology:Superior Antitumor Activity of Interleukin-12[J].Hum Gene Ther,1997,8(11):1303-1311.
